Howard Franklin
Chief Tech/Sci/R&D Officer en ASSERTIO HOLDINGS, INC. .
Perfil
Howard J.
Franklin is currently a Senior Vice President-Medical at Assertio Holdings, Inc. Prior to this, he worked as the Chief Medical Officer at Salix Pharmaceuticals Ltd.
from 2018 to 2022.
He also held the position of Chief Medical Officer at Finch Therapeutics Group, Inc. Dr. Franklin has an MBA from LaSalle University, an undergraduate degree from Lehigh University, and a doctorate from Drexel University College of Medicine.
Cargos activos de Howard Franklin
Empresas | Cargo | Inicio |
---|---|---|
ASSERTIO HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 06/03/2023 |
Antiguos cargos conocidos de Howard Franklin.
Empresas | Cargo | Fin |
---|---|---|
SALIX PHARMACEUTICALS, LTD. | Chief Tech/Sci/R&D Officer | 01/03/2022 |
FINCH THERAPEUTICS GROUP, INC. | Chief Tech/Sci/R&D Officer | - |
Formación de Howard Franklin.
LaSalle University | Masters Business Admin |
Lehigh University | Undergraduate Degree |
Drexel University College of Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
FINCH THERAPEUTICS GROUP, INC. | Health Services |
ASSERTIO HOLDINGS, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Salix Pharmaceuticals Ltd.
Salix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Salix Pharmaceuticals Ltd. develops and commercializes prescription drugs and medical devices used in the treatment of gastrointestinal diseases, endocrinology, hepatology, colorectal surgery, and internal medicine. It offers Anusol, Apriso, Colazal, Deflux, Diuril, Fenoglide, MoviPrep, Pepcid, Solesta, and Zegerid. The company was founded by randy W. Hamilton and Lorin K. Johnson in1989 and is headquartered in Bridgewater, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Howard Franklin